New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus

Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who developed d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:An Bras Dermatol
Main Authors: Pasin, Victor Pavan, Pereira, Amanda Regio, de Carvalho, Kalline Andrade, de Paiva, João Marcos Góes, Enokihara, Milvia Maria Simões e Silva, Porro, Adriana Maria
Format: Artigo
Jezik:Inglês
Izdano: Sociedade Brasileira de Dermatologia 2015
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540539/
https://ncbi.nlm.nih.gov/pubmed/26312705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20153672
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki